October 24, 2016
Genotype 6 is the last of the widely recognized hepatitis C subgroups. The small Southeast Asian country of Laos is the only country in which genotype 6 infects a majority of hepatitis C patients, although genotype 6 is also found in China, Korea, Taiwan and elsewhere in Southeast Asia. Genotype 6 comprises 5.4% of cases worldwide.
As with genotype 5, more data is needed to better support the best course of treatment for genotype 6 patients, but the evidence available shows relatively good cure rates with either sofosbuvir/ledipasvir or sofosbuvir/velpatasvir.
Credit: naruedom for iStock via Thinkstock.
Sony Salzman is a freelance journalist reporting on health care and medicine, who has won awards in both narrative writing and radio journalism. Follow Salzman on Twitter: @sonysalz.
No comments have been made.
The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.
|No Increased Risk of Liver Cancer After Hepatitis C Treatment With Direct-Acting Antivirals|
|This Week in HIV Research: Another Person Possibly Cured of HIV; and Long-Acting Rilpivirine Suppresses HIV in Rectal Tissue|
|This Week in HIV Research: HIV-Related Inflammation May Be Irreversible; and Genetically Engineered T-Cells Resist HIV|
|How Close Are We to a Cure for HIV? A Q&A With HIV Cure Scientific Superstars|
|Dolutegravir and the Central Nervous System: A Top HIV Clinical Development of 2016|